Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,534
Closed -$1.4M 27
2018
Q2
$1.4M Sell
40,534
-5,737
-12% -$196K 3.04% 15
2018
Q1
$1.56M Hold
46,271
3.13% 14
2017
Q4
$1.59M Buy
46,271
+4,743
+11% +$162K 3.05% 16
2017
Q3
$1.41M Hold
41,528
2.72% 18
2017
Q2
$1.32M Sell
41,528
-316
-0.8% -$9.96K 2.56% 19
2017
Q1
$1.36M Hold
41,844
2.64% 20
2016
Q4
$1.29M Sell
41,844
-632
-1% -$19.3K 2.63% 17
2016
Q3
$1.36M Buy
42,476
+1,054
+3% +$35.2K 2.68% 17
2016
Q2
$1.38M Buy
41,422
+2,635
+7% +$84.1K 2.92% 15
2016
Q1
$1.09M Buy
38,787
+2,846
+8% +$81.3K 2.39% 20
2015
Q4
$1.1M Buy
+35,941
New +$1.13M 2.65% 15
2015
Q2
Sell
-9,486
Closed -$313K 50
2015
Q1
$313K Hold
9,486
0.54% 43
2014
Q4
$280K Buy
9,486
+1,054
+13% +$30.2K 0.43% 49
2014
Q3
$237K Hold
8,432
0.35% 50
2014
Q2
$237K Sell
8,432
-6,851
-45% -$195K 0.31% 51
2014
Q1
$466K Sell
15,283
-2,108
-12% -$62.9K 0.61% 49
2013
Q4
$505K Hold
17,391
0.62% 48
2013
Q3
$474K Buy
17,391
+7,378
+74% +$201K 0.62% 48
2013
Q2
$266K Buy
+10,013
New +$277K 0.51% 36

Other funds holding PFE

P.R. Herzig & Co's PFE Position: Q3 2018 in Review

P.R. Herzig & Co sold out of Pfizer (PFE) in Q3 2018, closing a stake of 40,534 shares — an estimated $1.4M sold.

P.R. Herzig & Co first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $1.59M in Q4 2017. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • P.R. Herzig & Co reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
  • P.R. Herzig & Co sold 40,534 Pfizer shares in Q3 2018, an estimated $1.4M.
  • P.R. Herzig & Co first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • P.R. Herzig & Co's Pfizer position peaked at $1.59M in Q4 2017.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on P.R. Herzig & Co's 13F filing for Q3 2018.